期刊
CELL REPORTS
卷 9, 期 1, 页码 61-74出版社
CELL PRESS
DOI: 10.1016/j.celrep.2014.08.058
关键词
-
类别
资金
- Japan Society for the Promotion of Science
- CREST (JST)
- Dainippon Sumitomo Pharma Co., Ltd.
- ONSENDO Co., Ltd.
- Grants-in-Aid for Scientific Research [25253056, 221S0001, 24390196] Funding Source: KAKEN
Hepatocellular carcinoma (HCC) is a widespread fatal disease and the third most common cause of cancer deaths. Here, we show the potent anti-HCC effect of the circulating protein AIM. As in adipocytes, AIM is incorporated into normal hepatocytes, where it interferes with lipid storage. In contrast, AIM accumulates on the HCC cell surface and activates the complement cascade via inactivating multiple regulators of complement activation. This response provokes necrotic cell death specifically in AIM-bound HCC cells. Accordingly, AIM(-/-) mice were highly susceptible to steatosis-associated HCC development, whereas no AIM(+/+) mouse developed the disease despite comparable liver inflammation and fibrosis in response to a long-term high-fat diet. Administration of AIM prevented tumor development in AIM(-/-) mice, and HCC induction by diethylnitrosamine was more prominent in AIM(-/-) than wild-type mice. These findings could be the basis for novel AIM-based therapeutic strategies for HCC.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据